AkbariRad Mina, Allahyari Abolghasem, Ravanshad Sahar, Mahali Shima Nabavi, Ebrahimzadeh Farnoosh, Mozdourian Mahnaz, Javidarabshahi Zahra, Seddigh-Shamsi Mohsen, Emadzade Maryam, Ghalibaf AmirAli Moodi
Department of Internal Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Hematology Oncology, Mashhad University of Medical Sciences, Mashhad, Iran.
J Family Med Prim Care. 2022 May;11(5):1949-1956. doi: 10.4103/jfmpc.jfmpc_1368_21. Epub 2022 May 14.
Coronavirus disease 2019 (COVID-19) is a pulmonary involvement which was reported for the first time in December 2019 in the city of Wuhan, Hubei province, China. The aim of the study was to describe the demographic, clinical, laboratory, and radiological characteristics of 204 definitive laboratory-confirmed COVID-19 patients hospitalized in Mashhad, Khorasan Razavi province, Iran.
This study was performed on 204 laboratory-confirmed COVID-19 patients. A set of laboratory tests combined with various patient information and results from lung high-resolution computed tomography (HRCT) were gathered in a checklist and analyzed to give us a better view of patients who are hospitalized due to the complications caused by this disease.
The average age of our patients was 58.83 ± 15.93 years. There were 122 (59.8%) male and 82 (40.2%) female patients, and almost all of our patients had at least one underlying disease. Nine (4.4%) of our patients reported having gone for a trip to COVID-19-epidemic areas in the last 2 weeks. The most common signs shared among all our patients were cough, fever, and decreased O saturation; the average respiratory rate was 25.50 ± 6.74/min, average axillary body temperature was 37.69°C ± 0.69°C, and average O saturation was 88.34% ± 7.34%.
Based on our results, the most common signs of this disease are fever, cough, and shortness of breath, similar to seasonal influenza. Our data on disease severity showed that 33 (16.2%) patients had moderate disease, 139 (68.1%) had severe disease, and 28 (13.7%) were critical; 22 (10.8%) of our hospitalized patients died due to the complications of this disease.
2019年冠状病毒病(COVID-19)是一种肺部疾病,于2019年12月在中国湖北省武汉市首次报告。本研究的目的是描述伊朗霍拉桑拉扎维省马什哈德市204例实验室确诊的COVID-19住院患者的人口统计学、临床、实验室和放射学特征。
本研究对204例实验室确诊的COVID-19患者进行。一组实验室检查结合各种患者信息以及肺部高分辨率计算机断层扫描(HRCT)结果被收集在一份清单中并进行分析,以便更好地了解因该疾病并发症而住院的患者情况。
我们患者的平均年龄为58.83±15.93岁。有122例(59.8%)男性和82例(40.2%)女性患者,几乎所有患者都至少有一种基础疾病。9例(4.4%)患者报告在过去2周内去过COVID-19疫情地区。所有患者中最常见的症状是咳嗽、发热和血氧饱和度降低;平均呼吸频率为25.50±6.74次/分钟,平均腋温为37.69°C±0.69°C,平均血氧饱和度为88.34%±7.34%。
根据我们的结果,该疾病最常见的症状是发热、咳嗽和呼吸急促,与季节性流感相似。我们关于疾病严重程度的数据显示,33例(16.2%)患者为中度疾病,139例(68.1%)为重度疾病,28例(13.7%)为危重症;22例(10.8%)住院患者因该疾病并发症死亡。